US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 9, 2018 (9 years ago)

Amitriptyline HCl USP for prescription compounding

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

What was recalled

Amitriptyline HCl USP for prescription compounding , packaged in a) 25 g (NDC 58597-8003-4); b) 100 g (NDC 58597-8003-6); c) 500 g (NDC 58597-8003-7), d) 1000 g (NDC 58597-8003-8), RX only, packed by American Pharmaceutical Ingredients, 6650 Highland Road, Waterford, MI 48327.

Recalling firm
American Pharmaceutical Ingredients LLC
NDC code
58597-8003-4
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0474-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Amitriptyline recalls

See all
Class II · Moderate risk Terminated

S-Amitriptyline 10mg/Ml Mdv Inj Soln

Reason Lack of Assurance of Sterility

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy D-0198-2020
Class III · Low risk Terminated

Amitriptyline HCl Tablets

Reason Cross Contamination With Other Product: Imipramine

Sandoz Incorporated NDC 0781-1487-01 D-0943-2017
Class II · Moderate risk Terminated

Amitriptyline HCL Tablets

Reason Labeling: Label Mixup; potentially mislabeled

C. O. Truxton D-1115-2017
Class II · Moderate risk Terminated

Amitriptyline HCl active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-516-2015